Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
8318cover_PLED_tifcxd.JPG

May 2, 2005 Cover

Volume 83, Issue 18

Although a few firms using nanotechnology have gone public, venture capitalists still wait for a payoff from their investments

Credit:

Full Article
Volume 83 | Issue 18

All Issues

Business

Nanotech Investing

Although a few firms using nanotechnology have gone public, venture capitalists still wait for a payoff from their investments

  • Histone Methylation Proves Reversible

    Cells use transient methylation, demethylation to control access to tightly packed genome

  • Selling Drugs to Other Drug Firms

    India's Jubilant Organosys finds success as a company that only serves other companies

  • No Vote for U.S. in Chemicals Treaty

    First meeting under persistent organic pollutant pact takes place without U.S. as a treaty partner

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT